PwC joins Medicines Manufacturing Innovation Centre The global professional services firm has signed on the newest partner in the collaboration, aimed toward promoting innovation in pharma manufacturing.
CPI, one of the founding partners in the Medicines Manufacturing Innovation Centre, has announced the signing of an agreement with PwC, making the company the latest partner in the collaborative effort. The Centre (established via a partnership among CPI, the University of Strathclyde, UK Research and Innovation, Scottish Enterprise and founding industry partners AstraZeneca and GSK) seeks to promote more innovative drug manufacturing processes and enable a more agile supply chain.
PwC and the existing partners will work to maximize technological opportunities across the pharma supply chain. Efforts include the organization’s flagship Grand Challenge projects, intended to advance emergent and disruptive technologies. The program is partially funded by
Continuus lands $69.3m US drug manufacturing contract The small-molecule pharmaceuticals manufacturer secured a DoD/HHS government contract to manufacture critical medicines for a range of conditions.
Continuus Pharmaceuticals, a firm that uses proprietary integrated continuous manufacturing (ICM) technology to manufacture drugs, has been granted a $69.3m (57 EUR) contract to manufacture three different medicines. The contract, awarded by the US Department of Defense (DoD) and Department of Health and Human Services (HHS), also will be used for construction of the country’s first GMP-certified facility for ICM-driven facility of small-molecule marketed drugs, generic medicines and investigational therapies, through all clinical trial phases and the rest of a product’s lifecycle.
Sanofi unveils EUROAPI as name of new API company The global pharmaceutical firm expects big things from its newly formed active pharmaceutical ingredients company, to be led by new CEO Karl Rotthier.
Sanofi has unveiled EUROAPI as the name of its new European active pharmaceutical ingredients (API) company. Additionally, the firm has appointed Karl Rotthier as its future CEO.
According to Sanofi, the new company stands to be the largest API organization in the European Union, with projected sales of approximately €1b ($1.2b USD) by 2022. Additionally, the parent company anticipates EUROAPI will rank first on the continent in small-molecule APIs and second in the global API market.
Global alliance unites pharma pros to battle counterfeiting Fight the Fakes gathers manufacturers and other stakeholders to brainstorm on ways to combat falsified medicines and safeguard the world’s medicine supply.
Pharmaceutical counterfeiting is a widespread, pervasive problem that impacts not only pharma companies, but anyone who finds themselves in need of medicines. The minds behind Fight the Fakes launched the organization to bring together industry colleagues to work toward ways to thwart counterfeiters wherever they may strike.
Outsourcing-Pharma (OSP) recently spoke with Adam Aspinall (AA) chair of the Fight the Fakes Alliance, as well as senior director of access and product management for the Medicines for Malaria Venture about global counterfeiting, the group’s mission, accomplishments to date, and how individuals may join the organization in its work.
Authorities discovered the fake Pfizer erectile-dysfunction tablets in one of three cargo containers full of fraudulent goods, recently arrived from China.